SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-19-019706
Filing Date
2019-04-15
Accepted
2019-04-15 17:00:51
Documents
1
Period of Report
2019-03-15

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tv518868_form4.html 4  
1 OWNERSHIP DOCUMENT tv518868_form4.xml 4 3996
  Complete submission text file 0001144204-19-019706.txt   5480
Mailing Address 1185 AVENUE OF THE AMERICAS 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS 3RD FLOOR NEW YORK NY 10036 (973) 242-0005
Neurotrope, Inc. (Issuer) CIK: 0001513856 (see all company filings)

IRS No.: 463522381 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 780 THIRD AVENUE, 12TH FLOOR NEW YORK NY 10017
Business Address
Bernstein Bruce (Reporting) CIK: 0001665472 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38045 | Film No.: 19749143